about
Cloning and expression of human lecithin-cholesterol acyltransferase cDNACharacterization of an almost full-length cDNA coding for human blood coagulation factor XHuman complement component C3: cDNA coding sequence and derived primary structureIsolation and sequence of the cDNA for human protein S, a regulator of blood coagulationMolecular cloning of human ornithine aminotransferase mRNACharacterization of a cDNA coding for human factor VIICharacterization of a cDNA coding for human protein CProduction of a self-activating CBM-factor X fusion protein in a stable transformed Sf9 insect cell line using high cell density perfusion culture.Isolation of mouse N-CAM-related cDNA: detection and cloning using monoclonal antibodies.Factor XSanto Domingo. Evidence that the severe clinical phenotype arises from a mutation blocking secretion.The cDNA sequence of human endothelial cell multimerin. A unique protein with RGDS, coiled-coil, and epidermal growth factor-like domains and a carboxyl terminus similar to the globular domain of complement C1q and collagens type VIII and X.Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glu102Lys) in the second EGF-like domain.Characterization of a cDNA coding for sex steroid-binding protein of human plasma.Primary structure of human proacrosin deduced from its cDNA sequence.The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspotsMolecular basis of gamma-carboxylation. Role of the propeptide in the vitamin K-dependent proteins.Surface-loop residue Lys316 in blood coagulation Factor IX is a major determinant for Factor X but not antithrombin recognition.Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain.Affinity labeling, molecular cloning, and comparative amino acid sequence analyses of sex steroid-binding protein of plasma. A multidisciplinary approach for understanding steroid-protein interaction and its physiological role.The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII.Characterization of primary amino acid sequence of human complement control protein factor I from an analysis of cDNA clones.Intrinsic versus extrinsic coagulation. Kinetic considerations.Disulphide bridges of bovine factor X.The length of the linker between the epidermal growth factor-like domains in factor VIIa is critical for a productive interaction with tissue factor.Prothrombin residues 473-487 contribute to factor Va binding in the prothrombinase complex.Primary structure of the virus activating protease from chick embryo. Its identity with the blood clotting factor Xa.Congenital combined deficiency of coagulation factors VII and X--different genetic mechanisms.Haemophilia B mutations in a complete Swedish population sample: a test of new strategy for the genetic counselling of diseases with high mutational heterogeneity.Activation of prothrombin by ASP, a serine protease released from Aeromonas sobria.Cloning and structural analysis of leydin, a novel human serine protease expressed by the Leydig cells of the testis.Molecular abnormality observed in a patient with coagulation factor X (FX) deficiency: a novel three-base-pair (CTT) deletion within the polypyrimidine tract of the FX intron D.Similarities between a conserved sequence element of homoeo boxes and other genes.
P2860
Q24298679-5EE4B3EC-4B98-479C-A9B3-8FAF63D6BAAFQ24567735-2851FCC5-9D0F-4665-92B4-8481942FC21FQ24568206-BFAF6965-A600-4216-B8F8-C10735705C69Q24629960-FE6905A0-2AE9-45A2-9BC6-FAEE2172E89CQ28118667-765D13D9-11D2-4C58-AED6-A2A51CB9B1E9Q28646329-C7A57C7E-F9E3-4753-A568-5EF4A6B15D88Q28646338-D29CFFF8-9F8E-498B-855B-F27F5C133F13Q30462045-6077F276-5A70-4C15-AAC0-4E2DAEBF6107Q33931012-AF2246D8-DFFA-4753-BDA2-E1CAF03C0FFBQ34210223-8C337DCB-C5ED-4871-B28C-BFCA85ED0472Q34301760-F5A31797-D5FC-4D2F-B0F1-592AE925975FQ34304894-DBF1FCEB-2842-4B9A-88ED-3013F95E62F4Q34562984-D2871D39-1498-4999-AE53-CA64A91AE21FQ35189097-C3AE7981-C042-4C10-880D-324D850329A3Q35843460-FB572AAB-645D-4343-A723-C15BAD5FF6DDQ37711728-7252B451-33CD-4BEF-9139-755995DA56A4Q38308725-AFAB452F-5F2F-401E-A994-0719429BD31AQ41106800-B5A21BC6-9AED-4CE4-986F-8038E32D1C09Q41780943-F8EDD5BA-5044-43C9-8738-288B0780EA39Q41858297-5F10835C-8F40-4630-B106-ED0B456D0FF1Q41864928-9B1DD0C2-7FF6-42E0-81F1-0CC0C1685698Q41875932-A53824F1-A018-4969-B87B-D4D48E790FB1Q42856543-55AFA807-0483-47D7-9362-4B2F9C3DC95EQ43053276-CE4EB54A-5087-4F03-A632-00299E2B16B1Q45032492-67F54B0C-785A-4388-A5A8-202FA01C3B66Q45852709-2E30AD34-EBAF-42F4-8182-173129CD1843Q45871983-BA7A2DB0-752B-448E-A1AD-40A21DE1E9DFQ45881281-8711EB93-EB0F-4B28-9655-3A385B617A97Q46859604-E0B22E38-424B-43F7-8748-6D3F3F77EF97Q47975468-972D8A21-83B2-4F06-AA4E-B7F8BA5A5A94Q48023724-290BEECF-6142-46EB-8125-787D4DC4BCF9Q52466629-05F9D165-45B3-45BE-8616-6625EE89F5FC
P2860
description
1984 nî lūn-bûn
@nan
1984 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Characterization of a cDNA coding for human factor X
@ast
Characterization of a cDNA coding for human factor X
@en
Characterization of a cDNA coding for human factor X
@nl
type
label
Characterization of a cDNA coding for human factor X
@ast
Characterization of a cDNA coding for human factor X
@en
Characterization of a cDNA coding for human factor X
@nl
prefLabel
Characterization of a cDNA coding for human factor X
@ast
Characterization of a cDNA coding for human factor X
@en
Characterization of a cDNA coding for human factor X
@nl
P2093
P2860
P356
P1476
Characterization of a cDNA coding for human factor X
@en
P2093
P2860
P304
P356
10.1073/PNAS.81.12.3699
P407
P577
1984-06-01T00:00:00Z